Health
Novartis discontinues HCQ trial over enrollment challenges
Swiss drugmaker Novartis has announced to discontinue Hydroxychloroquine (HCQ) clinical trial over acute enrollment challenges that have made the completion of the trial infeasible,...
Record 237 single-day corona recoveries in Odisha
Odisha on Saturday reported a record recovery of 237 coronavirus patients in a single day, taking the total number of such patients to 3,534...
Glenmark launches Covid-19 drug in India
Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate Covid-19 cases after it received the Indian drug regulator's approval.
It will be...
New moms more like to suffer from depression, anxiety during COVID-19
Ladies, please take note. Researchers have stressed that new mothers are more likely to suffer from post-natal depression and anxiety during the COVID-19 pandemic.
The...
Delhi govt opposes LG order on institutional quarantine
The Delhi government on Saturday said that it could not reach a consensus on Lt. Governor Anil Baijal's decision of five-day compulsory institutional quarantine...
Popular